DD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DuPont De Nemours Inc (DD) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock shows some positive technical indicators and has a favorable analyst rating, the lack of significant recent growth in financial performance, neutral insider and hedge fund activity, and no strong proprietary trading signals suggest holding off for now. The upcoming Q1 earnings report on May 5, 2026, could provide better clarity on the company's trajectory.
The technical indicators for DD are moderately positive. The MACD histogram is above zero, indicating bullish momentum, and the moving averages (SMA_5 > SMA_20 > SMA_200) suggest an upward trend. However, the RSI is neutral at 54.626, and the stock is trading near its pivot level of 46.55, with resistance at 47.831 and support at 45.268. Overall, the technicals suggest a mild upward trend but no strong breakout signal.
Analysts maintain a generally positive outlook, with multiple firms keeping Buy or Outperform ratings and price targets in the range of $52 to $
The company has announced a quarterly dividend of $0.20 per share, reflecting a commitment to shareholder returns.
DuPont's recent launch of new chromatography resins indicates ongoing innovation and potential market opportunities.
Financial performance in Q4 2025 showed minimal growth, with revenue flat YoY and a net income loss of $126 million.
Stock trend analysis suggests a potential decline of -3.27% in the next week and -11.78% in the next month.
Neutral insider and hedge fund activity, with no significant trading trends in recent months.
In Q4 2025, DuPont's revenue remained flat YoY, and net income improved slightly but remained negative at -$126 million. EPS increased to -0.3, up 7.14% YoY, while gross margin improved to 30.25%. These metrics indicate some operational improvements but no significant growth.
Analysts are generally optimistic about DuPont, with recent price targets ranging from $52 to $60 and consistent Buy or Outperform ratings. Citi, Deutsche Bank, JPMorgan, and others highlight the company's potential for EPS growth, margin improvement, and recovery in diversified end-markets.
